US2016103134A1PendingUtilityA1
Device and method for separating and analyzing blood
Individually held — no corporate assignee on recordPriority: May 14, 2008Filed: Oct 13, 2015Published: Apr 14, 2016
Est. expiryMay 14, 2028(~1.8 yrs left)· nominal 20-yr term from priority
G01N 33/491G01N 33/68G01N 33/54366G01N 2333/47G01N 33/92
38
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides a device for detecting FABP in a blood sample from a patient, methods for analyzing blood on the presence of FABP, as well as methods and kits for the detection of FABP in a blood sample from a patient.
Claims
exact text as granted — not AI-modified1 . A method for analyzing blood for the presence of FABP, which comprises separating blood into at least plasma and red blood cells, and collecting at least the plasma in a collector,
wherein the FABP present in the blood is contacted with at least one antibody that specifically binds with FABP, and wherein the binding between the antibody and the FABP can be observed from the outside of said collector.
2 . The method of claim 1 , wherein a predetermined amount of blood is taken from a blood sample and introduced in a device, wherein it is mixed with a predetermined amount of diluent in order to obtain a desired dilution, whereafter the diluted blood is pressed against a filter, such that blood plasma is forced through said filter and into said collector and red blood cells are held back by the filter.
3 . The method of claim 1 , wherein said plasma is contacted with said antibody in said collector.
4 . The method of claim 1 , wherein a detection-antibody is used against a first epitope of FABP, and wherein said detection-antibody is conjugated with a detectable label and contacts the separated plasma.
5 . The method of claim 4 , wherein a capture-antibody is used against a second epitope of FABP which is different from said first epitope, wherein said capture-antibody is capable of being immobilized in said collector and contacts the separated plasma.
6 . The method of claim 1 , wherein said FABP is selected from the group consisting of H-FABP, L FABP, I-FABP, ILBP, B-FABP, A-FABP, E-FABP, T-FABP and M-FABP.
7 . The method of claim 1 , wherein said FABP is contacted with at least two different types of antibody.
8 . A method for analyzing blood for the presence of FABP, which comprises separating blood into at least plasma and red blood cells, and collecting at least the plasma in a collector,
wherein the plasma is contacted with at least one antibody that specifically binds with FABP present in said plasma, and wherein the binding between the antibody and the FABP can be observed from the outside of said collector.
9 . The method of claim 8 , wherein a predetermined amount of blood is taken from a blood sample and introduced in a device, wherein it is mixed with a predetermined amount of diluent in order to obtain a desired dilution, whereafter the diluted blood is pressed against a filter, such that blood plasma is forced through said filter and into said collector and red blood cells are held back by the filter.
10 . The method of claim 8 , wherein said plasma is contacted with said antibody in said collector.
11 . The method of claim 8 , wherein a detection-antibody is used against a first epitope of FABP, and wherein said detection-antibody is conjugated with a detectable label and contacts the separated plasma.
12 . The method of claim 11 , wherein a capture-antibody is used against a second epitope of FABP which is different from said first epitope, wherein said capture-antibody is capable of being immobilized in said collector and contacts the separated plasma.
13 . The method of claim 8 , wherein said FABP is selected from the group consisting of H-FABP, L FABP, I-FABP, ILBP, B-FABP, A-FABP, E-FABP, T-FABP and M-FABP.
14 . The method of claim 8 , wherein said FABP is contacted with at least two different types of antibody.
15 . The method of claim 1 , providing a test result within 3 minutes.
16 . The method of claim 15 , providing a test result within 2 minutes, from the time of administration of a blood sample.
17 . The method of claim 8 , providing a test result within 3 minutes.
18 . The method of claim 17 , providing a test result within 2 minutes, from the time of administration of a blood sample.Join the waitlist — get patent alerts
Track US2016103134A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.